Need professional-grade analysis? Visit stockanalysis.com
$10.27B
N/A
N/A
N/A
Price Chart
Risk-Adjusted Performance
Also Listed On
Madrigal Pharmaceuticals Inc (MDGL) Price Performance
Madrigal Pharmaceuticals Inc (MDGL) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $445.04, up 0.88% from the previous close.
Over the past year, MDGL has traded between a low of $267.56 and a high of $602.83. The stock has gained 33.3% over this period. It is currently 26.2% below its 52-week high.
Madrigal Pharmaceuticals Inc has a market capitalization of $10.27B.
About Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Company Info
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $958.40M
- EBITDA
- $-298,591,008
- Profit Margin
- -30.08%
- EPS (TTM)
- -12.85
- Book Value
- 26.39
Technical Indicators
- 52 Week High
- $615.00
- 52 Week Low
- $265.00
- 50 Day MA
- $482.29
- 200 Day MA
- $433.17
- Beta
- -0.96
Valuation
- Trailing P/E
- N/A
- Forward P/E
- 34.99
- Price/Sales
- 10.72
- Price/Book
- 16.97
- Enterprise Value
- $9.63B